Down 3.2% today with small-cap biotech stocks: 13 of 17 are down, 2.0% on average; the S&P 500 is down 0.3%.
Lags the market
Down 18% over five years while the S&P 500 rose 76%; up 30% in the past year.
ACHV's Quality Score fell 1 point on Mon, Nov 2, to -2.
Follow ACHV's trial news. Pro members can get an alert when Achieve Life Sciences files news, and see its trials, share raises, and its CEO's filings.
We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.
| Holding it back | 169.6% more shares than a year ago |
| Latest filing | 8-K, Oct 1 |
TodayWith its group.
Achieve Life Sciences filed an 8-K reporting a change of CFO
ACHV closed −3.9% the next session (Oct 2).
After its last 4 reports it closed -6.6% on average, higher 1 of 4 times.
About 15 quarters
Director Richard Alistair Stewart sold 20,626 shares on Aug 19.
Decision dates and advisory committee meetings the companies have announced in their filings, soonest first and small companies first.
Poorfor quality, not price, 0 of 14 chart checks firingWhat the Quality Score means
ACHV is #61 of 92 by Quality Score.
| 1 | ||
| 2 | ||
| 3 | ||
| Open for its score | ||
| Open for its score | ||
| Open for its score | ||
| Open for its score | ||
| 61 |
Net income over four quarters: ACHV -$114M, LXRX -$61.1M, OLMA -$205M, MLTX -$264M.
Expected to report Thu Nov 5, before the open (in 3 days). Expected.
What an earnings report is: every 3 months, a company tells everyone how much it sold and earned. We read the figures, the outlook, and how the stock moved after.
The figures are not read from the release yet.
ACHV's results filing gives no sales by line in a table we read.
No outlook figures read from this release.
“Anticipates potential FDA approval in the first half of 2027, followed by U.S. commercial launch”
From its results filing (SEC filing · Aug 11)
| Reported | Gap | Reaction | 5 sessions |
|---|---|---|---|
| Aug 11, 2026 | 0.0% | -1.2% | +11.1% |
| May 12, 2026 | -4.3% | +7.2% | -14.7% |
| Mar 24, 2026 | -9.6% | -28.4% | -34.1% |
One insider sold $175K across 1 filing in the last 6 months. No open-market buys on record. The newest:
Officers and directors with a Form 4 in the last 12 months.
In ETFs: ACHV is under 0.1% of VTI, the most of the 24 funds Breakaway covers, by their holdings as filed for Jun 30, 2026.
Achieve Life Sciences Inc is a late-stage specialty pharmaceutical company focused on the world-wide development and commercialization of cytisinicline as a treatment for nicotine dependence. Its New Drug Application (NDA) for cytisinicline for smoking cessation in adults is supported by two completed Phase 3 studies and an open-label long-term safety study. It has also completed a Phase 2 study of cytisinicline in nicotine e-cigarette cessation, conducted an end-of-Phase 2 meeting with the FDA, and has received Breakthrough Therapy designation for the vaping cessation indication.
ACHV scores -2 today, which Breakaway calls Poor. It is #61 of 92 in Pharma by Quality Score, with 0 of 14 chart checks firing. Down 18% over five years while the S&P 500 rose 76%; up 30% in the past year. Cash lasts about 15 quarters at its spending (to Jun 30). Breakaway does not say whether to buy any stock: the score does not know your situation, and it is not a recommendation to buy or sell anything. Please do your own research.
ACHV scores -2 today, which Breakaway calls Poor (below zero). That is #61 of 92 in Pharma by Quality Score. The score adds up the chart checks, the trend, the company's filed sales, its profits, the news, insider trades, and Congress trades. The section above lists the lines behind ACHV's -2.
One insider sold $175K across 1 filing in the last 6 months. No open-market buys on record. The newest is Richard Alistair Stewart, Director, who sold $175K on Aug 19.
Only on the public pages, which run at least 15 minutes behind. Pro members, and anyone on a guest pass, see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included.